The John B Pierce Laboratory
New Haven, Connecticut, 06519, United States
NCT Number: NCT02335008
The goal of this study is to test the hypothesis that repeated consumption of artificial sweetener reduces sweet taste intensity.
Looking for future studies?
Notify Me18 year–45 year
All sexes
Interventional
Not applicable
New Haven, Connecticut, 06519, United States
Significant controversy surrounds the possibility that consumption of artificial sweeteners (AFS) leads to weight gain. Some studies have found correlations between AFS use and weight gain and/or diabetes [1-4] while others have indicated that AFSs may aid in weight loss [5] or have no effects on body mass index (BMI) [6]. In rats, exposure to AFS leads to reduced chow intake following a sweet preload [7, 8], higher body weight [9, 10] and increased glucose responses and decreased GLP1 release following an oral glucose tolerance test [11] compared to exposure to caloric sweeteners. Given that the five FDA approved AFSs are found in thousands of foods [12] this marks a clear and significant gap in knowledge. Our preliminary data demonstrate a 3-fold decrease in sweet taste sensitivity following consumption of a beverage sweetened with two packets of Splenda for just 10 days. These data provide strong evidence that repeated exposure to sucralose reduces perception of sweet taste intensity, most likely by down-regulation of the sweet taste receptor. Therefore, it is imperative that we gain a greater understanding of the consequences of AFS use, since alterations in sweet taste perception that occur in response to AFS exposure may promote weight gain.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2 packets per 12 fl oz
equisweet to sucralose
Time frame: up to one week after intervention
general labeled magnitude scale ratings of taste intensity
Yale University
Other
The Effect of Artificial Sweeteners (AFS) on Sweetness Sensitivity and Preference - Pilot Study
Acronym: AFS_pilot
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02335021
Glucose Metabolism Disorders, Hyperinsulinism
New Haven, Connecticut, United States
View Trial Details